✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

KMS Medisurgi Ltd.

KMSMEDI

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹42 Cr.
P/E
95.31

KMS Medisurgi Ltd.

  • KMS Medisurgi
  • Amkay Products
  • Centenial Surgical

FAQs on KMS Medisurgi Ltd. Shareprice

KMS Medisurgi has given better returns compared to its competitors.
KMS Medisurgi has grown at ~1.2% over the last 1yrs while peers have grown at a median rate of -28.0%

Yes, KMS Medisurgi is expensive.
Latest PE of KMS Medisurgi is 95.31, while 3 year average PE is 82.41.
Also latest EV/EBITDA of KMS Medisurgi is 29.62 while 3yr average is 24.63.

View FAQ's On Business

Growth Table

  • KMS Medisurgi Ltd.
  • Amkay Products
  • Centenial Surgical

Balance Sheet

  • KMS Medisurgi Ltd.
  • Amkay Products
  • Centenial Surgical

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • KMS Medisurgi Ltd.
  • Amkay Products
  • Centenial Surgical

Cash Flow

  • KMS Medisurgi Ltd.
  • Amkay Products
  • Centenial Surgical

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • KMS Medisurgi Ltd.
  • Amkay Products
  • Centenial Surgical

Quarterly Results

  • KMS Medisurgi Ltd.
  • Amkay Products
  • Centenial Surgical

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on KMS Medisurgi Ltd. Financials

Balance sheet of KMS Medisurgi is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of KMS Medisurgi is increasing.
Latest net debt of KMS Medisurgi is ₹0.37 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹0.01 Crs.

The profit is oscillating.
The profit of KMS Medisurgi is ₹0.59 Crs for TTM, ₹0.44 Crs for Mar 2025 and ₹0.45 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
KMS Medisurgi latest dividend payout ratio is 3.75% and 3yr average dividend payout ratio is 3.42%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech